Insights

Gathering insights about Quil…

Similar companies to Quil

Quil Tech Stack

Quil uses 8 technology products and services including Facebook Pixel, Amazon Web Services, Firebase, and more. Explore Quil's tech stack below.

Facebook Pixel
Analytics
Amazon Web Services
Cloud Hosting
Firebase
Database
Google Fonts API
Font Scripts
PHP
Programming Languages
Google Tag Manager
Tag Management
MouseFlow
Web Analytics
SVG Support
Web Platform Extensions

Media & News

Equillium to Participate in Upcoming Investor Conferences
LA JOLLA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:
Nov 20, 2025 | www.globenewswire.com
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
Closed financing of up to $50 million; initial tranche of $30 million provides runway through 2027 Hosted key opinion leader event highlighting the important role of the Aryl Hydrocarbon Receptor (AhR) in intestinal inflammation, the unmet medical need in ulcerative colitis, and the potential clinical utility of EQ504, a novel oral AhR modulator EQ504 Phase 1 clinical study initiation planned for mid-2026 LA JOLLA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for its third fiscal quarter ended September 30, 2025.
Nov 13, 2025 | www.globenewswire.com
Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript
Equillium, Inc. ( EQ ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases November 5, 2025 12:00 PM EST Company Participants Bruce Steel - Co-Founder, CEO & Director Stephen Connelly - Chief Scientific Officer & President Francisco Quintana Brian Gordon Feagan Conference Call Participants Thomas Smith - Leerink Partners LLC, Research Division Cha Cha Yang - Jefferies LLC, Research Division Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Brian Feagan Catherine Novack - JonesTrading Institutional Services, LLC, Research Division Min Lee - Guggenheim Securities, LLC, Research Division Presentation Operator Good afternoon, and welcome to the Equillium Bio Virtual KOL Event.
Nov 05, 2025 | seekingalpha.com
Equillium to Participate in Upcoming Investor Conferences
LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences: Stifel Healthcare Conference Format: Company Presentation & 1x1 Meetings Date: Wednesday, November 12, 2025 Time: 3:20-3:50 PM EDT Jefferies Global Healthcare Conference in London Format: 1x1 Meetings Date: Tuesday, November 18 – Thursday, November 20, 2025 Members of the Equillium management team will be available to participate in meetings with investors who are registered to attend the conference.
Nov 04, 2025 | www.globenewswire.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LA JOLLA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on October 31, 2025, the Compensation Committee of Equillium's Board of Directors granted inducement awards consisting of nonstatutory stock options to purchase a total of 7,200 shares of common stock to a new employee under Equillium's 2024 Inducement Plan.
Nov 03, 2025 | www.globenewswire.com
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis
Oct 22, 2025 | www.globenewswire.com
Equillium Announces Leadership and Corporate Updates
LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Equillium , Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced changes to its Board of Directors (BoD) and senior leadership, and other corporate updates.
Oct 06, 2025 | www.globenewswire.com

Quil's Email Address Formats

Quil uses at least 1 format(s):

Quil Email Formats	Example	Percentage
FLast@quilhealth.com	JDoe@quilhealth.com	49%
First@quilhealth.com	John@quilhealth.com	1%
FLast@quilhealth.com	JDoe@quilhealth.com	49%
First@quilhealth.com	John@quilhealth.com	1%

Frequently Asked Questions

Where is Quil's headquarters located?

Quil's main headquarters is located at Philadelphia, Pennsylvania 19103 US. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is Quil's stock symbol?

Quil is a publicly traded company; the company's stock symbol is EQ.

What is Quil's official website and social media links?

Quil's official website is quilhealth.com and has social profiles on LinkedIn Crunchbase.

What is Quil's NAICS code?

Quil's NAICS code is 71394 - Fitness and Recreational Sports Centers.

How many employees does Quil have currently?

As of October 2025, Quil has approximately 70 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Vice President Of Content: M. G.Executive Assistant To Chief Executive Officer: C. E.Senior Vice President Engineering: A. A.. Explore Quil's employee directory with LeadIQ.

What industry does Quil belong to?

Quil operates in the Wellness and Fitness Services industry.

What technology does Quil use?

Quil's tech stack includes Facebook PixelAmazon Web ServicesFirebaseGoogle Fonts APIPHPGoogle Tag ManagerMouseFlowSVG Support.

What is Quil's email format?

Quil's email format typically follows the pattern of FLast@quilhealth.com. Find more Quil email formats with LeadIQ.

When was Quil founded?

Quil was founded in 2018.

Quil

Q: What is Quil's official website and social media links?

Quil's official website is quilhealth.com. Quil has social profiles on LinkedIn.

Q: How many employees does Quil have currently?

Quil has approximately 70 employees.

Q: What technology does Quil use?

Quil's tech stack includes OWL Carousel, Gravity Forms, Flywheel, MySQL, Hoefler&Co.

Wellness and Fitness ServicesPennsylvania, United States51-200 Employees

Quil, the joint venture between Independence Health Group (Independence) and Comcast.   We create technology that helps people thrive, age on their own terms, and fosters connections with those who support them.  Quil Assure is the modern medical alert system designed to support older adults live full and independent lives supported by those who care for them.  Quil serves older adults, patients, members, and their caregivers in partnership with their healthcare providers and health plans nationally. We are headquartered in Philadelphia, PA.